Wellcome Trust in association with Nature Genetics is pleased to announce the third Genomics of Common Diseases meeting.

The Genomics of Common Diseases 2009
September 23-26, 2009
Wellcome Trust Conference Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK

The meeting is at capacity with a waitlist.

The availability of whole-genome association studies and emerging "next-generation" sequencing technologies are redefining the genetic architecture of common diseases, revealing new susceptibility genes and offering new clues about mechanisms for a wide range of health disorders. The strategic focus of common disease genetics is progressing from the identification of susceptibility genes - with remarkable successes in the last two years - to understanding the extent to which rare and common variants explain inherited susceptibility to common diseases, to discovery of new disease mechanisms, and to pioneer and evaluate transfer of these advances through to potential clinical application.

Wellcome Trust and Nature Genetics are proud to announce the third annual conference in this series of "The Genomics of Common Diseases," bringing together leading participants in this field. The meeting will address the following topics:

  • The state of the art in genome-wide association studies, across a range of common diseases, including whole genome sequencing
  • Population genetics, statistics and evolution including common disease challenges in different populations, and biobanks
  • Efforts to translate common disease genetics to the clinic and to the healthy population, incorporating pharmacogenomics, genomic profiling, utility of risk prediction, public health
  • Genomics of common cancers and heritable cancer susceptibility
  • Cell and animal models of common disease genetics
  • The role of epigenomics in common diseases
  • Ethical, legal and social implications of personal genetic information

The Genomics of Common Diseases 2009

  • Organizers

    • Timothy Aitman (Imperial College London, UK)
    • David Altshuler (Broad Institute of MIT and Harvard, USA)
    • Myles Axton (Nature Genetics, USA)
    • Peter Donnelly (University of Oxford, UK)
    • Richard Gibbs (Baylor College of Medicine, USA)
    • Leena Peltonen (Wellcome Trust Sanger Institute, UK)
    • Nazneen Rahman (Institute of Cancer Research, UK)

  • Date

    September 23-26, 2009

  • Venue

    Wellcome Trust Conference Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK